Human parvovirus B19 infection with GvHD-like erythema in two allogeneic stem cell transplant recipients [4]

Bone Marrow Transplantation

Volumn 39, Issue 5, 2007, Pages 315-316

  Muetherig, A ^a   Christopeit, M ^a   Muller L P ^a   Grothe, W ^a   Weber, T ^a   Theurich, S ^a   Behre, G ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; CYCLOSPORIN; FLUDARABINE; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; THYMOCYTE ANTIBODY;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ADULT; ALLOGENEIC STEM CELL TRANSPLANTATION; ANTIBODY TITER; BONE MARROW BIOPSY; BREAST CANCER; CASE REPORT; DIFFERENTIAL DIAGNOSIS; ERYTHEMA INFECTIOSUM; ERYTHROCYTE TRANSFUSION; FEMALE; GRAFT RECIPIENT; HISTOPATHOLOGY; HUMAN; LABORATORY TEST; LETTER; PARVOVIRUS; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRIORITY JOURNAL; SKIN BIOPSY; THROMBOCYTE TRANSFUSION; WHOLE BODY RADIATION;

DIAGNOSIS, DIFFERENTIAL; ERYTHEMA INFECTIOSUM; FEMALE; GRAFT VS HOST DISEASE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MIDDLE AGED; PARVOVIRUS B19, HUMAN; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 33847322007     PISSN: 02683369     EISSN: 14765365     Source Type: Journal    
DOI: 10.1038/sj.bmt.1705589     Document Type: Letter

References (9)

1. Ang HA, Apperley JF, Ward KN. Persistence of antibody to human parvovirus B19 after allogeneic bone marrow transplantation: Role of prior recipient immunity. Blood 1997; 89: 4646-4651.
2. Brown KE, Young NS. Parvovirus B19 infection and hematopoiesis. Blood Rev 1995; 9: 176-182.
3. Solano C, Juan O, Gimeno C, Garcia-Conde J. Engraftment failure associated with peripheral blood stem cell transplantation after B19 parvovirus infection. Blood 1996; 88: 1515-1517.
4. Heegaard ED, Petersen BL. Parvovirus B19 transmitted by bone marrow. Br J Haematol 2000; 111: 659-661.
5. Plentz A, Hahn J, Knöll A, Holler E, Jilg W, Modrow S. Exposure of hematologic patients to parvovirus B19 as a contaminant of blood cell preparations and blood products. Transfusion 2005; 45: 1811-1815.
6. Bonvicini F, Gallinella G, Gentilomi GA, Ambretti S, Musiani M, Zerbini M. Prevention of iatrogenic transmission of B19 infection: Different approaches to detect, remove or inactivate virus contamination. Clin Lab 2006; 52: 263-268.
7. Eid AJ, Brown RA, Patel R, Razonable RR. Parvovirus B19 infection after transplantation: A review of 98 cases. Clin Infect Dis 2006; 43: 40-48.
8. Hayes-Lattin B, Seipel TJ, Gatter K, Heinrich MC, Maziarz RT. Pure red cell aplasia associated with parvovirus B19 infection occurring late after allogeneic bone marrow transplantation. Am J Hematol 2004; 75: 142-145.
9. Mouthon L, Guillevin L, Tellier Z. Intravenous immunglobulins in autoimmune- or parvovirus B19 pure red cell aplasia. Autoimmun Rev 2005; 4: 264-269.